<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">858</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2021-2-58-61</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Gout: what's new in the clinical guidelines</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Prozherina</surname><given-names>Yuliya</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shirokova</surname><given-names>Irina</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">RM Analytics</aff><aff id="aff-2">Remedium </aff><pub-date date-type="epub" iso-8601-date="2021-12-14" publication-format="electronic"><day>14</day><month>12</month><year>2021</year></pub-date><issue>2</issue><fpage>58</fpage><lpage>61</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-17"><day>17</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2021,</copyright-statement><copyright-year>2021</copyright-year></permissions><abstract>Over the past two decades we have seen a breakthrough in the study of gout, one of the most common inflammatory joint diseases representing a great challenge for both patients and the healthcare system. The international and Russian guidelines for the treatment of patients with gout have been improved and updated in the light of scientific achievements and their successful application in real practice. For example, the guidelines of the American College of Rheumatology (ACR) that discuss new strategies for managing patients with gout were changed and added in 2020 [1].</abstract><kwd-group xml:lang="en"><kwd>gout</kwd><kwd>urate-lowering therapy</kwd><kwd>febuxostat</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>подагра</kwd><kwd>уратснижающая терапия</kwd><kwd>фебуксостат</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Громова М.А., Цурко В.В. Новые рекомендации Американской коллегии ревматологов по ведению больных подагрой (2020). Комментарии к некоторым позициям. РМЖ. Медицинское обозрение. 2021;5(2):89—95. https://doi.org/10.32364/2587-6821-2021-5-2-89-95.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Дзяк Г.В., Коваленко В.Н., Хомазюк Т.А. Подагра: взгляд в будущее. Киев: МОРИОН; 2020. 192 с.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Светлова М.С. Клинические проявления, диагностика и лечение подагры в практике врача первичного звена. Медицинский совет. 2020;(4):136–142. https://doi.org/10.21518/2079-701X-2020-4-136-142.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Макаренко Е.В. Подагра: современные принципы диагностики и лечения. Вестник ВГМУ. 2017;16(6):7—22.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>FitzGerald J.D., Dalbeth N., Mikuls T. et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020;72(6):744—760. https://doi.org/10.1002/acr.24180.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Погожева Е.Ю., Амирджанова В.Н., Каратеев А.Е. Современные рекомендации по лечению подагры: фокус на уратснижающую терапию. Трудный пациент. 2020;18(3). https://doi.org/10.24411/2074-1995-2018-10016.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Обновленные рекомендации по лечению подагры. Дата публикации 03.07.2020. Режим доступа: https://internist.ru/publications/detail/obnovlennye-rekomendatsii-po-lecheniyupodagry.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Беляева Е.А. Подагра: современные представления. Клиническая медицина и фармакология. 2019;5(1):2–14.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Владимиров С.А., Елисеев М.С., Ильиных Е.В. и др. Подагра: клинические рекомендации. М.; 2018. Режим доступа: https://legalacts.ru/doc/klinicheskie-rekomendatsii-podagra-utvminzdravom-rossii.</mixed-citation></ref></ref-list></back></article>
